iA Global Asset Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$197K Hold
783
– – ﹤0.01% 436
2026
Q1
$170K Sell
783
-1,067
-58% -$237K ﹤0.01% 376
2025
Q4
$423K Sell
1,850
-3,059
-62% -$697K 0.01% 346
2025
Q3
$1.14M Sell
4,909
-216
-4% -$44K 0.02% 293
2025
Q2
$951K Buy
5,125
+805
+19% +$150K 0.01% 291
2025
Q1
$905K Sell
4,320
-11,905
-73% -$2.31M 0.02% 307
2024
Q4
$2.88M Sell
16,225
-6,505
-29% -$1.2M 0.05% 204
2024
Q3
$4.49M Sell
22,730
-67,780
-75% -$12.6M 0.08% 173
2024
Q2
$15.5M Buy
90,510
+7,718
+9% +$1.28M 0.3% 68
2024
Q1
$15.1M Sell
82,792
-6,433
-7% -$1.11M 0.31% 70
2023
Q4
$13.8M Sell
89,225
-65,231
-42% -$9.51M 0.32% 67
2023
Q3
$23M Buy
154,456
+7,199
+5% +$1.06M 0.61% 38
2023
Q2
$19.8M Buy
+147,257
New +$21.6M 0.53% 46

Other funds holding ABBV

iA Global Asset Management's ABBV Position: Q2 2026 in Review

iA Global Asset Management held its AbbVie (ABBV) position steady in Q2 2026 at 783 shares worth $197K. The position accounts for ﹤0.01% of the portfolio, ranked #436.

iA Global Asset Management first reported a position in ABBV in Q2 2023 and has held it in 13 quarters since. The position peaked at $23M in Q3 2023. 4,234 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • iA Global Asset Management held 783 shares of AbbVie worth $197K as of Q2 2026.
  • iA Global Asset Management left its AbbVie share count unchanged in Q2 2026.
  • AbbVie made up ﹤0.01% of iA Global Asset Management's portfolio in Q2 2026, its #436 holding.
  • iA Global Asset Management first reported a position in AbbVie in Q2 2023 and has held it in 13 quarters since.
  • iA Global Asset Management's AbbVie position peaked at $23M in Q3 2023.
  • 4,234 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on iA Global Asset Management's 13F filing for Q2 2026, filed 29 Jul 2026.